Are you handling the increased complexity of oncology forecasts?

Oncology forecasting has become significantly more complex for two main reasons: First, the knock-on effects of improving efficacy (which we call the tsunami effect). Second, the increasing control that regulators and payers are exercising over which lines of therapy products can be used in (which we call the “shadows and lights” effect). In this article, we discuss these complexities and the importance of incorporating them into your forecasts.


Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top